Combined treatment for bladder pain syndrome
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a combination of a medication called pregabalin with education and behavioral counseling to see if it improves bladder pain and urgent, frequent urination in people with bladder pain syndrome/interstitial cystitis (a condition causing long-term bladder pain and urinary symptoms).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with bladder pain syndrome/interstitial cystitis (IC/BPS).
- You have had urinary symptoms (like pain or discomfort, urgency, or frequency) on most days for the past 3 months.
- In the last 4 weeks, you rated your bladder pain/discomfort or urinary urgency/frequency as 3 or higher on a 0-10 scale.
- You are not pregnant or breastfeeding, and you do not have certain severe medical or psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the antidepressant venlafaxine, combined with education and behavior changes, can reduce pain and urinary urgency in people with bladder pain syndrome (interstitial cystitis).
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This trial tests a new nerve stimulation approach for women with bladder pain syndrome. It aims to find a gentler way to reduce pain and urgency without surgery.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
This trial tests whether a nerve-based therapy called EA can reduce bladder pain. It also aims to understand why the treatment may help by looking at underlying mechanisms.
Hear when a new Bladder Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.